隆基股份(601012.SH)再創歷史新高市值突破1500億 年內累漲超60%
格隆匯6月29日丨2020年光伏競價項目結果最新出爐,總規模遠超預期,光伏股全線上漲,其中,隆基股份(601012.SH)延續近期強勢繼續上漲,盤中一度漲8%再創歷史新高價41.03元,現漲6.53%報40.48元,最新總市值1530億元。該股年內累漲超60%。隆基近日聯合六家光伏企業倡議發佈M10硅片標準。另外,6月25日,隆基發佈最新單晶硅片價格公示,單晶硅片P型M6 175μm厚度(166/223mm),價格為2.62元/片,單晶硅片P型158.75/223mm 175μm厚度,價格2.53元/片。連續五次降價後,隆基股份單晶硅片價格終於止跌回穩。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.